Global Trichomonas Rapid Testing Market Size by Type (Cassette Rapid Test, Rapid Test Strip, Rapid Test Swab), by End User (Hospitals, Specialty Clinics, Diagnostic Lab) & Region - Key Manufacturers, Analysis, Growth Trends, and Forecast till 2026

  • Category : Healthcare and Pharma
  • |
  • ID : 1261440
  • |
  • Publishe Date : September 2019
  • |
  • No of Pages: 121
  • |
  • Publisher : Intellectual Research Partners

Trichomoniasis is the most common curable and non-viral sexually transmitted infection (STI). It is caused by a protozoan parasite called trichomonas vaginalis. It is detected using microscopic detection methods such as wet mount and cell culture, which have low sensitivity and take ample time compared to advanced trichomonas rapid testing methods such as antigen detection and molecular-based techniques, which have high sensitivity and specificity.

The global trichomonas rapid testing market was estimated to be valued at USD XX million in 2018 and is projected to reach USD XX million by 2026, at a CAGR of XX% during 2019 to 2026. The Trichomonas rapid testing market is witnessing significant growth, owing to increasing prevalence of HIV infection and risk of transmitting infection to the new-born. In addition doctors recommend trichomonas rapid testing for pregnant women. However, high cost of treatment is one of the major factors expected to hamper the growth of the global market.

The global trichomonas rapid testing market is primarily segmented based on different type, end user and regions. On the basis of type, the market is divided into cassette rapid test kit, rapid test strip, rapid test swab, molecule-based rapid test kit and others. Depending on end user, it is categorized into hospitals, specialty clinics, diagnostic laboratories and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, South America, and MEA.

On the basis of type, the market is split into:
* Cassette Rapid Test Kit
* Rapid Test Strip
* Rapid Test Swab
* Molecule-Based Rapid Test Kit

On the basis of end user, the market is split into:
* Hospitals
* Specialty Clinics
* Diagnostic Laboratories
* Others

Moreover, the market is classified based on regions and countries as follows:
* North America- U.S., Canada
* Europe- U.K., France, Germany, Italy and Rest of Europe
* Asia-Pacific- China, Japan, India and Rest of Asia Pacific
* South America- Brazil, Mexico and Rest of South America
* Middle East & Africa- South Africa, Saudi Arabia and Rest of Middle East & Africa

Key Market Players:
The key players profiled in the market include:
* Sekisui Diagnostics (Sekisui Chemical)
* Cepheid
* Quidel Corporation
* Becton, Dickinson and Company
* Hologic, Inc.
* Creative Diagnostics
* Koroglu Medical Devices
* Nal Von Minden GmbH
* Jei Daniel Biotech Corp
* Nanjing Liming Bio-products Co., Ltd

These enterprises are focusing on growth strategies, such as new product launches, expansions, acquisitions, and agreements & partnerships to expand their operations across the globe.

Key Benefits of the Report:
* Global, regional, country, type and end user market size and their forecast from 2015-2026
* Identification and detailed analysis on key market dynamics, such as, drivers, restraints, opportunities, and challenges influencing growth of the market
* Detailed analysis on industry outlook with market specific PESTLE, and supply chain to better understand the market and build expansion strategies
* Identification of key market players and comprehensively analyze their market share and core competencies, detailed financial positions, key products, and unique selling points
* Analysis on key players’ strategic initiatives and competitive developments, such as joint ventures, mergers, and new product launches in the market
* Expert interviews and their insights on market shift, current and future outlook, and factors impacting vendors’ short term and long term strategies
* Detailed insights on emerging regions, type and end user with qualitative and quantitative information and facts

Target Audience:
* Trichomonas Rapid Testing Treatment Providers
* Traders, Importers, and Exporters
* Raw Material Suppliers and Distributors
* Research and Consulting Firms
* Government and Research Organizations
* Associations and Industry Bodies

Research Methodology:
The market is derived through extensive use of secondary, primary, in-house research followed by expert validation and third party perspective, such as, analyst reports of investment banks. The secondary research is the primary base of our study wherein we conducted extensive data mining, referring to verified data sources, such as, white papers, government and regulatory published articles, technical journals, trade magazines, and paid data sources.

For forecasting, regional demand & supply factors, recent investments, market dynamics including technical growth scenario, consumer behavior, and end use trends and dynamics, and production capacity were taken into consideration. Different weightages have been assigned to these parameters and quantified their market impacts using the weighted average analysis to derive the market growth rate.

The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs), which typically include:
* Manufacturers
* Suppliers
* Distributors
* Government Body & Associations
* Research Institutes

TABLE OF CONTENTS

1. Introduction

2. Research Methodology

3. Executive Summary

4. Global Trichomonas Rapid Testing Market Overview
4.1. Market Segmentation & Scope
4.2. Market Trends
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Supply Chain Analysis
4.3. Global Trichomonas Rapid Testing Market - Porter\'s Five Forces Analysis
4.4. Global Trichomonas Rapid Testing Market - PESTEL Analysis

5. Global Trichomonas Rapid Testing Market, by Type
5.1. Global Trichomonas Rapid Testing Market, Size and Forecast, 2015-2026
5.2. Global Trichomonas Rapid Testing Market, by Cassette Rapid Test Kit, 2015-2026
5.2.1. Key driving factors, trends and opportunities
5.2.2. Market size and forecast, 2015-2026
5.3. Global Trichomonas Rapid Testing Market, by Rapid Test Strip, 2015-2026
5.3.1. Key driving factors, trends and opportunities
5.3.2. Market size and forecast, 2015-2026
5.4. Global Trichomonas Rapid Testing Market, by Molecule-Based Rapid Test Kit, 2015-2026
5.4.1. Key driving factors, trends and opportunities
5.4.2. Market size and forecast, 2015-2026
5.5. Global Trichomonas Rapid Testing Market, by Rapid Test Swab, 2015-2026
5.5.1. Key driving factors, trends and opportunities
5.5.2. Market size and forecast, 2015-2026

6. Global Trichomonas Rapid Testing Market, by End User
6.1. Global Trichomonas Rapid Testing Market, Size and Forecast, 2015-2026
6.2. Global Trichomonas Rapid Testing Market, by Hospitals, 2015-2026
6.2.1. Key driving factors, trends and opportunities
6.2.2. Market size and forecast, 2015-2026
6.3. Global Trichomonas Rapid Testing Market, by Specialty Clinics, 2015-2026
6.3.1. Key driving factors, trends and opportunities
6.3.2. Market size and forecast, 2015-2026
6.4. Global Trichomonas Rapid Testing Market, by Diagnostic Laboratories, 2015-2026
6.4.1. Key driving factors, trends and opportunities
6.4.2. Market size and forecast, 2015-2026
6.5. Global Trichomonas Rapid Testing Market, by Others, 2015-2026
6.5.1. Key driving factors, trends and opportunities
6.5.2. Market size and forecast, 2015-2026

7. Global Trichomonas Rapid Testing Market, by Region
7.1. Trichomonas Rapid Testing Market Regional Analysis, 2015-2026
7.2. Global Trichomonas Rapid Testing Market Revenue (USD Million) by Region, 2015-2026
7.3. North America Trichomonas Rapid Testing Market, 2015-2026
7.3.1. North America Trichomonas Rapid Testing Market Size and Forecast, 2015-2026
7.3.2. North America Trichomonas Rapid Testing Market by Country, 2015-2026
7.3.2.1. U.S. Trichomonas Rapid Testing Market, 2015-2026
7.3.2.2. Canada Trichomonas Rapid Testing Market, 2015-2026
7.4. Europe Trichomonas Rapid Testing Market, 2015-2026
7.4.1. Europe Trichomonas Rapid Testing Market Size and Forecast, 2015-2026
7.4.2. Europe Trichomonas Rapid Testing Market by Country, 2015-2026
7.4.2.1. Germany Trichomonas Rapid Testing Market, 2015-2026
7.4.2.2. France Trichomonas Rapid Testing Market, 2015-2026
7.4.2.3. Italy Trichomonas Rapid Testing Market, 2015-2026
7.4.2.4. UK Trichomonas Rapid Testing Market, 2015-2026
7.4.2.5. Spain Trichomonas Rapid Testing Market, 2015-2026
7.4.2.6. Rest of Europe Trichomonas Rapid Testing Market, 2015-2026
7.5. Asia Pacific Trichomonas Rapid Testing Market, 2015-2026
7.5.1. Asia Pacific Trichomonas Rapid Testing Market Size and Forecast, 2015-2026
7.5.2. Asia Pacific Trichomonas Rapid Testing Market by Country, 2015-2026
7.5.2.1. Japan Trichomonas Rapid Testing Market, 2015-2026
7.5.2.2. China Trichomonas Rapid Testing Market, 2015-2026
7.5.2.3. India Trichomonas Rapid Testing Market, 2015-2026
7.5.2.4. Rest of Asia Pacific Trichomonas Rapid Testing Market, 2015-2026
7.6. South America Trichomonas Rapid Testing Market, 2015-2026
7.6.1. South America Trichomonas Rapid Testing Market Size and Forecast, 2015-2026
7.6.2. South America Trichomonas Rapid Testing Market by Country, 2015-2026
7.6.2.1. Mexico Trichomonas Rapid Testing Market, 2015-2026
7.6.2.2. Brazil Trichomonas Rapid Testing Market, 2015-2026
7.6.2.3. Rest of South America Trichomonas Rapid Testing Market, 2015-2026
7.7. Middle East & Africa Trichomonas Rapid Testing Market, 2015-2026
7.7.1. Middle East & Africa Trichomonas Rapid Testing Market Size and Forecast, 2015-2026
7.7.2. Middle East & Africa Trichomonas Rapid Testing Market by Country, 2015-2026
7.7.2.1. Saudi Arabia Trichomonas Rapid Testing Market, 2015-2026
7.7.2.2. South Africa Trichomonas Rapid Testing Market, 2015-2026
7.7.2.3. Rest of Middle East & Africa Trichomonas Rapid Testing Market, 2015-2026

8. Competitive Landscape
8.1. Introduction
8.2. Market Share Analysis/Top Player Positioning, 2018

9. Company Profiles
9.1. Sekisui Diagnostics (Sekisui Chemical)
9.1.1. Company Overview
9.1.2. Financial Overview
9.1.3. Product Benchmarking
9.1.4. Key Developments
9.2. Cepheid
9.2.1. Company Overview
9.2.2. Financial Overview
9.2.3. Product Benchmarking
9.2.4. Key Developments
9.3. Quidel Corporation
9.3.1. Company Overview
9.3.2. Financial Overview
9.3.3. Product Benchmarking
9.3.4. Key Developments
9.4. Becton, Dickinson and Company
9.4.1. Company Overview
9.4.2. Financial Overview
9.4.3. Product Benchmarking
9.4.4. Key Developments
9.5. Hologic, Inc.
9.5.1. Company Overview
9.5.2. Financial Overview
9.5.3. Product Benchmarking
9.5.4. Key Developments
9.6. Creative Diagnostics
9.6.1. Company Overview
9.6.2. Financial Overview
9.6.3. Product Benchmarking
9.6.4. Key Developments
9.7. Koroglu Medical Devices
9.7.1. Company Overview
9.7.2. Financial Overview
9.7.3. Product Benchmarking
9.7.4. Key Developments
9.8. Nal Von Minden GmbH
9.8.1. Company Overview
9.8.2. Financial Overview
9.8.3. Product Benchmarking
9.8.4. Key Developments
9.9. Jei Daniel Biotech Corp
9.9.1. Company Overview
9.9.2. Financial Overview
9.9.3. Product Benchmarking
9.9.4. Key Developments
9.10. Nanjing Liming Bio-products Co., Ltd
9.10.1. Company Overview
9.10.2. Financial Overview
9.10.3. Product Benchmarking
9.10.4. Key Developments

10. Key Insights

Content are not available

Choose License Type